Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexes

Gene Therapy

Volumn 3, Issue 4, 1996, Pages 287-297

  Ebbinghaus, S W ^a   Vigneswaran, N ^a   Miller, C R ^a   Chee Awai, R A ^a   Mayfield, C A ^a   Curiel, D T ^a   Miller, D M ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Gene therapy; HER 2 neu oncogene; k ras oncogene; Liposomes; Receptor mediated endocytosis

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIPID; LUCIFERASE; NUCLEIC ACID; POLYLYSINE;

ADENOVIRUS; ARTICLE; CANCER CELL; CELL MEMBRANE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL POPULATION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; ONCOGENE; PRIORITY JOURNAL;

ADENOVIRUSES, HUMAN; BASE SEQUENCE; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT, ACTIVE; BREAST NEOPLASMS; FEMALE; GENETIC VECTORS; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASMS; OLIGONUCLEOTIDES; OVARIAN NEOPLASMS; POLYLYSINE; TUMOR CELLS, CULTURED; WILMS TUMOR;

ADENOVIRIDAE;

EID: 0029911788     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Zamecnik P et al. Electron micrographic studies of transport of oligodeoxynucleotides across eukaryotic cell membranes. Proc Natl Acad Sci USA 1994; 91: 3156-3160.
2. Yakubov LA et al. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci USA 1989; 86: 6454-6458.
3. Stein CA et al. Dynamics of the internalization of phosphodiester oligodeoxynucleotides in h160 cells. Biochemistry 1993; 32: 4855-4861.
4. Budker VG, Knorre DG, Vlassov VV. Cell membranes as barriers for antisense constructions. Antisense Res Dev 1992; 2: 177-184 (review).
5. Akhtar S, Juliano RL. Cellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell Biol 1992; 2: 139-144.
6. Temsamani J et al. Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. Antisense Res Dev 1994; 4: 35-42.
7. Mayfield C et al. Triplex formation by the human ha-ras promoter inhibits sp1 binding and in vitro transcription. J Biol Chem 1994; 269: 18232-18238.
8. Ebbinghaus SW et al. Triplex formation inhibits her-2/neu transcription in vitro. J Clin Invest 1993; 92: 2433-2439.
9. Young SL, Krawczyk SH, Matteucci MD, Toole JJ. Triple helix formation inhibits transcription elongation in vitro. Proc Natl Acad Sci USA 1991; 88: 10023-10026.
10. McShan WM et al. Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices J Biol Chem 1992, 267: 5712-5721.
11. Postel EH, Flint SJ, Kessler DJ, Hogan ME. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in Hela cells, thereby reducing c-myc mRNA levels. Proc Natl Acad Sci USA 1991; 88: 8227-8231.
12. Orson FM et al. Oligonucleotide inhibition of IL2r alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes. Nucleic Acids Res 1991; 19: 3435-3441.
13. Fisher TL, Terhorst T, Cao X, Wagner RW. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acids Res 1993; 21: 3857-3865.
14. Ghosh MK, Ghosh K, Dahl O, Cohen JS. Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application. Nucleic Acids Res 1993; 21: 5761-5766.
15. Agrawal S, Temsamani J, Tang JY. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci USA 1991; 88: 7595-7599.
16. Ghosh MK, Ghosh K, Cohen JS. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application. Anticancer Drug Des 1993; 8: 15-32.
17. Akhtar S, Kole R, Juliano RL. Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci 1991; 49: 1793-1801.
18. IS Campbell JM, Bacon TA, Wickstrom E. Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid. J Biochem Biophys Meth 1990; 20: 259-267.
19. Hacia JG, Wold BJ, Dervan PB. Phosphorothioate oligonucleotide-directed triple helix formation. Biochemistry 1994; 33: 5367-5369.
20. Maury G et al. Rapid determination of the affinity of 28- and 14-mer phosphorothioate oligonucleotides for HIV-1 reverse transcriptase by fluorescence spectroscopy. Biochim Biophys Acta 1993; 19: 1-8.
21. Kibler-Herzog L et al. Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers. Nucleic Acids Res 1991; 19: 2979-2986.
22. Murakami A et al. Interaction of antisense DNA with nucleic acids/proteins. Nucleic Acids Symp Ser 1992; 27: 123-124.
23. Morvan F et al. Comparative evaluation of seven oligonucleotide analogues as potential antisense agents. J Med Chem 1993; 36: 280-287.
24. Ho PT, Ishiguro K, Wickstrom E, Sartorelli AC. Non-sequence-specific inhibition of transferrin receptor expression in hl-60 leukemia cells by phosphorothioate oligodeoxynucleotides. Antisense Res Dev 1991; 1: 329-342.
25. Dahm SC, Uhlenbeck OC. Role of divalent metal ions in the hammerhead RNA cleavage reaction. Biochemistry 1991; 30: 9464-9469.
26. Capaccioli S et al. Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Commun 1993; 197: 818-825, and erratum 1994; 200: 1769.
27. Juliano RL, Akhtar S. Liposomes as a drug delivery system for antisense oligonucleotides. Antisense Res Dev 1992; 2: 165-176 (review).
28. Zatloukal K et al. In vivo production of human factor VII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery. Proc Natl Acad Sci USA 1994; 91: 5148-5152.
29. Gao L et al. Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes. Hum Gene Ther 1993; 4: 17-24.
30. Wagner E et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 1992; 89: 6099-6103.
31. Curiel DT et al High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Hum Gene Ther 1992; 3: 147-154.
32. Seth P, Rosenfeld M, Higginbotham J, Crystal RG. Mechanism of enhancement of DNA expression consequent to cointernalization of a replication-deficient adenovirus and unmodified plasrrud DNA. J Viral 1994; 68: 933-940.
33. Michael SI et al. Binding-incompetent adenovirus facilitates molecular conjugate-mediated gene transfer by the receptor-mediated endocytosis pathway. J Biol Chem 1993; 268: 6866-6869.
34. Defer C, Belin MT, Caillet-Boudin ML, Boulanger P. Human adenovirus-host cell interactions: comparative study with members of subgroups b and c. J Virol 1990; 64: 3661-3673.
35. Mayfield C, Squibb M, Miller D. Inhibition of nuclear protein binding to the human ki-ras promoter by triplex-forming oligonucleotides. Biochemistry 1994; 33: 3358-3363.
36. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
37. Howell KE, Devaney E, Gruenberg J. Subcellular fractionation of tissue culture cells. Trends Biochem Sci 1989; 14: 44-47.
38. Jones N, Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 1979; 17: 683-689.
39. Chardonnet Y, Dales S. Early events in the interaction of adenoviruses with Hela cells. I. Penetration of type 5 and intracellular release of the DNA genome. Virology 1970; 40: 462-477.
40. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase n in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475-1489.
41. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982; 218: 474-475.
42. Noonberg SB, Garovoy MR, Hunt CA. Characteristics of oligonucleotide uptake in human keratinocyte cultures. J Invest Dermatol 1993; 101: 727-731.